The Cell and Gene Therapy Access Model

Key Points

• Negotiation outcomes from the Cell and Gene Therapy Access Model reveal important insights for healthcare policy.
• Lessons from the first negotiation cycle can enhance future models for access to cell and gene therapies.
• The viewpoint addresses the implications for both Medicare and Medicaid in the context of emerging therapies.
• Understanding these lessons is critical for improving healthcare accessibility and funding for innovative treatments.